Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19

por Lowe, David M., Brown, Li-An K., Chowdhury, Kashfia, Davey, Stephanie, Yee, Philip, Ikeji, Felicia, Ndoutoumou, Amalia, Shah, Divya, Lennon, Alexander, Rai, Abhulya, Agyeman, Akosua A., Checkley, Anna, Longley, Nicola, Dehbi, Hakim-Moulay, Freemantle, Nick, Breuer, Judith, Standing, Joseph F.
Publicado 2022